Distribución de variantes del virus del papiloma humano 16 (VPH 16) en mujeres con y sin neoplasia intraepitelial cervical grado 3 y cáncer cervical

Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008, cancer incidence and mortality worldwide: IARC CancerBase No. 10. Lyon, France: International Agency for Research on Cancer; 2010.

Yang BH, Bray FI, Parkin DM, Sellors JW, Zhang ZF. Cervical cancer as a priority for prevention in different world regions: an evaluation using years of life lost. Int J Cancer 2004;109:418-24.

https://doi.org/10.1002/ijc.11719

Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002; 55:244-65.

https://doi.org/10.1136/jcp.55.4.244

Clifford GM, Smith JS, Plummer M, Muñoz N, Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer.2003;88:63-73.

https://doi.org/10.1038/sj.bjc.6600688

Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsague X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348:518-27.

https://doi.org/10.1056/NEJMoa021641

Khan MJ, Castle PE, Lorincz AT, Wacholder S, Sherman M, Scott DR, et al. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of typespecific HPV testing in clinical practice. J Natl Cancer Inst. 2005;97:1072-9.

https://doi.org/10.1093/jnci/dji187

Schiffman M, Herrero R, Desalle R, Hildesheim A, Wacholder S, Rodriguez AC, et al. The carcinogenicity of human papillomavirus types reflects viral evolution. Virology. 2005;337:76-84.

https://doi.org/10.1016/j.virol.2005.04.002

Myers G. Human Papillomaviruses, 1996. A compilation and analysis of nucleic acid and amino acid sequences. Los Álamos: National Laboratory; 1996.

https://doi.org/10.2172/463607

de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of papillomaviruses. Virology .2004;324:17-27.

https://doi.org/10.1016/j.virol.2004.03.033

Bernard HU. The clinical importance of the nomenclature, evolution and taxonomy of human papillomaviruses. J Clin Virol. 2005;32(Suppl 1):S1-6.

https://doi.org/10.1016/j.jcv.2004.10.021

Huertas-Salgado A, Martín-Gámez DC, Moreno P, Murillo R, Bravo MM, Villa L, et al. E6 molecular variants of human papillomavirus (HPV) type 16: an updated and unified criterion for clustering and nomenclature. Virology. 2011;410:201-15.

https://doi.org/10.1016/j.virol.2010.10.039

Yamada T, Wheeler CM, Halpern AL, Stewart AC, Hildesheim A, Jenison SA. Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments. J Virol. 1995;69:7743-53.

https://doi.org/10.1128/JVI.69.12.7743-7753.1995

Villa L, Sichero L, Rahal P, Caballero O, Ferenczy A, Rohan T, et al. Molecular Variants of Human Papillomavirus Types 16 and 18 Preferentially Associated with Cervical Neoplasia. J Gen Virol. 2000;81:2959-68.

https://doi.org/10.1099/0022-1317-81-12-2959

Berumen J, Ordoñez RM, Lazcano E, Salmeron J, Galvan SC, Estrada RA, et al. Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. J Natl Cancer Inst. 2001;93:1325-30.

https://doi.org/10.1093/jnci/93.17.1325

Xi LF, Carter JJ, Galloway DA, Kuypers J, Hughes JP, Lee SK, et al. Acquisition and natural history of human papillomavirus type 16 variant infection among a cohort of female university students. Cancer Epidemiol Biomarkers Prev. 2002;11:343-51.

Burk RD, Terai M, Gravitt PE, Brinton LA, Kurman RJ, Barnes WA, et al. Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix. Cancer Res. 2003;63:7215-20.

de Boer MA, Peters LA, Aziz MF, Siregar B, Cornain S, Vrede MA, et al. Human papillomavirus type 16 E6, E7, and L1 variants in cervical cancer in Indonesia, Suriname, and The Netherlands. Gynecol Oncol. 2004;94:488-94.

https://doi.org/10.1016/j.ygyno.2004.05.037

Tornesello ML, Duraturo ML, Salatiello I, Buonaguro L, Losito S, Botti G, et al. Analysis of human papillomavirus type-16 variants in Italian women with cervical intraepithelial neoplasia and cervical cancer. J Med Virol. 2004;74:117-26.

https://doi.org/10.1002/jmv.20154

Zehbe I, Wilander E, Delius H, Tommasino M. Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphisms. Lancet. 1998;352:1441-2.

https://doi.org/10.1016/S0140-6736(05)61263-9

Londesborough P, Ho L, Terry G, Cuzick J, Wheeler C, Singer A. Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities. Int J Cancer. 1996;69:364-8.

https://doi.org/10.1002/(SICI)1097-0215(19961021)69:5<364::AID-IJC2>3.0.CO;2-3

Rojas W, Parra MV, Campo O, Caro MA, Lopera JG, Arias W, et al. Genetic make up and structure of Colombian populations by means of uniparental and biparental DNA markers. Am J Phys Anthropol. 2010;143:13-20.

https://doi.org/10.1002/ajpa.21270

Gornick MC, Castellsague X, Sanchez G, Giordano TJ, Vinco M, Greenson JK, et al. Human papillomavirus is not associated with colorectal cancer in a large international study. Cancer Causes Control. 2010;21:737-43.

https://doi.org/10.1007/s10552-010-9502-0

van den Brule AJ, Pol R, Fransen-Daalmeijer N, Schouls LM, Meijer CJ, Snijders PJ. GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol. 2002;40:779-87.

https://doi.org/10.1128/JCM.40.3.779-787.2002

Molano M, Van den Brule A, Plummer M, Weiderpass E, Posso H, Arslan A, et al. Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology: a population-based, 5-year follow- up study. Am J Epidemiol. 2003;158:486-94.

https://doi.org/10.1093/aje/kwg171

Schlecht NF, Burk RD, Palefsky JM, Minkoff H, Xue X, Massad LS, et al. Variants of human papillomaviruses 16 and 18 and their natural history in human immunodeficiency virus-positive women. J Gen Virol. 2005;86:2709-20.

https://doi.org/10.1099/vir.0.81060-0

Molano M, Huertas-Salgado A. A Method for Detection and Identification of HPV 16 Variants Using Primers and Probes. World Intellectual Property Organization (WIPO) 2010. PCT No: WO/2010/125420. Disponible en "http://www.wipo.int/pctdb".

Sánchez GI, Kleter B, Gheit T, van Doorn LJ, de Koning MN, de Sanjosé S, et al. Clinical evaluation of polymerase chain reaction reverse hybridization assay for detection and identification of human papillomavirus type 16 variants. J Clin Virol 2011;51:165-9.

https://doi.org/10.1016/j.jcv.2011.03.013

R Project for Statistical Computing. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0 [internet]. 2010. [citado: 25 de abril de 2012]. Disponible en: http://www.R-project.org

Bravo MM. Variantes moleculares en el gen L1 del virus del papiloma humano tipo 16, y regiones de la proteína L1 probablemente involucradas en la interacción viruscélula epitelial. IATREA. 2004;17:314.

Junes-Gill K, Sichero L, Maciag PC, Mello W, Noronha V, Villa LL. Human papillomavirus type 16 variants in cervical cancer from an admixtured population in Brazil. J Med Virol. 2008;80:1639-45.

https://doi.org/10.1002/jmv.21238

Muñoz N, Bosch FX, de Sanjosé S, Tafur L, Izarzugaza I, Gili M, et al. The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int J Cancer. 1992;52:743-9.

https://doi.org/10.1002/ijc.2910520513

Bosch FX, Muñooz N, de Sanjosé S, Navarro C, Moreo P, Ascunce N, et al. Human papillomavirus and cervical intraepithelial neoplasia grade III/carcinoma in situ: a case-control study in Spain and Colombia. Cancer Epidemiol Biomarkers Prev. 1993;2:415-22.

Villa LL, Costa RL, Petta CA, Andrade RP, Paavonen J, Iversen OE, et al. High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow- up. Br J Cancer. 2006;95:1459-66.

https://doi.org/10.1038/sj.bjc.6603469

Harper DM, Franco EL, Wheeler CM, Moscicki AB, Romanowski B, Roteli-Martins CM, et al. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet. 2006;367:1247-55.

https://doi.org/10.1016/S0140-6736(06)68439-0

Denny L, Kuhn L, Hu CC, Tsai WY, Wright TC, Jr. Human papillomavirus-based cervical cancer prevention: long-term results of a randomized screening trial. J Natl Cancer Inst. 2010;102:1557-67.

https://doi.org/10.1093/jnci/djq342

Huertas-Salgado A. Presencia y persistencia de variantes de VPH 16 en mujeres con citología normal y en mujeres que desarrollaron lesiones intraepiteliales cervicales de alto grado, de la cohorte de Bogotá. Bogotá: Universidad Nacional de Colombia; 2008.

Molano M, Posso H, Weiderpass E, van den Brule AJ, Ronderos M, Franceschi S, et al. Prevalence and determinants of HPV infection among Colombian women with normal cytology. Br J Cancer. 2002;87:324-33.

https://doi.org/10.1038/sj.bjc.6600442

López-Revilla R, Pineda MA, Ortiz-Valdez J, Sánchez- Garza M, Riego L. Human papillomavirus type 16 variants in cervical intraepithelial neoplasia and invasive carcinoma in San Luis Potosí City, Mexico. Infect Agent Cancer. 2009;4:3.

https://doi.org/10.1186/1750-9378-4-3

González-Losa M, Laviada Mier y Tera M, Puerto-Solis M, García-Carranca A. Molecular variants of HPV type 16 E6 among Mexican women with LSIL and invasive cancer. J Clin Virol. 2004;29:95-8.

https://doi.org/10.1016/S1386-6532(03)00094-5

Yamada T, Manos MM, Peto J, Greer CE, Muñoz N, Bosch FX, et al. Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol. 1997;71:2463-72.

https://doi.org/10.1128/JVI.71.3.2463-2472.1997

Bedoya G, Montoya P, Garcia J, Soto I, Bourgeois S, Carvajal L, et al. Admixture dynamics in Hispanics: A shift in the nuclear genetic ancestry of a South American population isolate. Proc Natl Acad Sci U S A. 2006;103:7234-9.

https://doi.org/10.1073/pnas.0508716103

Ben-Ezra J, Johnson DA, Rossi J, Cook N, Wu A. Effect of fixation on the amplification of nucleic acids from paraffin-embedded material by the polymerase chain reaction. J Histochem Cytochem. 1991;39:351-4.

https://doi.org/10.1177/39.3.1704393

García P, Benavente F, Melo A, Roa I, Roa JC. Efecto de la fijación en la calidad del ADN: estudio controlado con cinco fijadores. Rev Españ Patol. 2006;39:5.

Steinau M, Patel SS,Unger ER. Efficient DNA extraction for HPV genotyping in formalin-fixed, paraffinembedded tissues. J Mol Diagn. 2011;13:377-81.

https://doi.org/10.1016/j.jmoldx.2011.03.007

Quint KD, de Koning MN, van Doorn LJ, Quint WG, Pirog EC. HPV genotyping and HPV16 variant analysis in glandular and squamous neoplastic lesions of the uterine cervix. Gynecol Oncol. 2010;117:297-301.

https://doi.org/10.1016/j.ygyno.2010.02.003

Tornesello ML, Losito S, Benincasa G, Fulciniti F, Botti G, Greggi S, et al. Human papillomavirus (HPV) genotypes and HPV16 variants and risk of adenocarcinoma and squamous cell carcinoma of the cervix. Gynecol Oncol. 2011;121:32-42.

https://doi.org/10.5555/test_2013-02-26x

Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F, et al. Role of a p53 polymorphism in the development of human papillomavirus-associated Cancer. Nature. 1998;393:229-34.

https://doi.org/10.1038/30400

Lichtig H, Algrisi M, Botzer LE, Abadi T, Verbitzky, Jackman A, et al. HPV16 E6 natural variants exhibit different activities in functional assays relevant to the carcinogenic potential of E6. Virology. 2006;350:216-27.

https://doi.org/10.1016/j.virol.2006.01.038

Zehbe I, Mytilineos J, Wikstrom I, Henriksen R, Edler L, Tommasino M. Association between human papillomavirus 16 E6 variants and human leukocyte antigen class I polymorphism in cervical cancer of Swedish women. Hum Immunol. 2003;64:538-42.

https://doi.org/10.1016/S0198-8859(03)00033-8

Chen Z, Terai M, Fu L, Herrero R, DeSalle R, Burk RD. et al. Diversifying selection in human papillomavirus type 16 lineages based on complete genome analyses. J Virol. 2005;79:7014-23.

https://doi.org/10.1128/JVI.79.11.7014-7023.2005